Majesco's Famous Games (BloodRayne Among Them) Through GameTap!

Majesco Entertainment, provider of video games and digital entertainment products, has just revealed to the press a very fruitful agreement with GameTap, the leader in digital game distribution and broadband entertainment today. Under the terms of the agreement, Majesco will be making available for subscription and download its most popular titles.

Some of the games from the catalog, include Psychonauts, BloodRayne 1 & 2, and JAWS Unleashed.

"Given the limited shelf space and relatively quick turn of titles at retail nowadays, we consider GameTap to be a valuable vehicle that can help extend the video game lifecycle," said Ken Gold, vice president of Marketing, Majesco.

An official report informs that along with Psychonauts from Double Fine Productions (currently available for subscription play and online purchase), BloodRayne 1 & 2 are also prominently featured as part of GameTap’s "Bloodsucker Summer," which is an original content program that the 900+ game service utilizes to bring both newer and older titles from their massive library to the attention of their subscribers.

GameTap is also inviting fans to ‘Hit the Beach’ today by offering the best-selling JAWS Unleashed to their Gold Level members for the first time, according to the same piece. Ricardo Sanchez, GameTap’s vice president of content and creative director, explained:

"Majesco’s wide range of quality games are a great addition to our current product catalog," said Sanchez. "Psychonauts is consistently one of our top titles and we’ve had a great response to the recent launch of BloodRayne on our service."

Psychonauts is a third-person psychic odyssey, JAWS Unleashed lets you play as one of nature's most powerful and fearsome creatures, the Great White Shark while BloodRayne (which I'm sure you're already very familiar with) is an action-horror series of games starring a hot, supernatural heroine called Rayne, just so everyone's on the same level. That's her in the image to the top left side of the article by the way...